AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Sitabetic-M 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Kepran Healthcare

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitabetic-M 50/500 Tablet

Diabetol-Duo 50/500mg tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent severe diabetic complications like vision impairment and kidney disease, potentially lowering the risk of stroke or heart attack. Diabetol-Duo 50/500mg may be used alone or in conjunction with other diabetes treatments. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and other medications. Taking it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under your physician's guidance. Adherence to your prescribed diet and exercise plan is crucial for diabetes management; lifestyle significantly impacts control. Common side effects include nausea, vomiting, diarrhea, stomach discomfort, headache, and sore throat. Low blood sugar (hypoglycemia) is a potential side effect, particularly when combined with insulin or sulfonylureas; learn to recognize and address this. This medication isn't for everyone. Inform your doctor of any pre-existing kidney, liver, heart, or pancreatic conditions, or excessive alcohol consumption before starting treatment. Pregnant or breastfeeding individuals should consult their physician. Interactions with other medications are possible; disclose all medications to ensure safety. Alcohol should be limited due to its blood sugar-lowering effect. Your doctor will monitor your kidney function and blood sugar levels throughout treatment.

Primary Ingredients of Sitabetic-M 50/500 Tablet

There is no text provided to rephrase.

Uses of Sitabetic-M 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Sitabetic-M 50/500 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Sitabetic-M 50/500 Tablet whole; avoid chewing, crushing, or fracturing it. This medication should be taken with a meal.

Common Side effects of Sitabetic-M 50/500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitabetic-M 50/500 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Sitabetic-M 50/500 Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Sitabetic-M 50/500 Tablet works:

Sitabetic-M 50/500 tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and boosts insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitabetic-M 50/500 Tablet with alcohol is strongly discouraged due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitabetic-M 50/500 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the potential advantages against possible risks prior to prescribing this medication. Seek medical advice before taking this medicine.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitabetic-M 50/500 tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Sitabetic-M 50/500 Tablets, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Sitabetic-M 50/500 Tablets. Medical supervision, including regular kidney function assessments, is recommended during treatment.

LiverLiverUNSAFE

The use of Sitabetic-M 50/500 Tablets is likely contraindicated in individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Sitabetic-M 50/500 Tablet :

Should you forget a dose of Sitabetic-M 50/500 Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitabetic-M 50/500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitabetic-M 50/500 Tablet

Sitabetic-M 50/500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged Sitabetic-M 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitabetic-M 50/500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitabetic-M 50/500 Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitabetic-M 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (like Sitabetic-M 50/500) can cause lactic acidosis, a serious, potentially fatal condition involving high blood lactic acid levels (also known as MALA – Metformin-associated lactic acidosis). This rare side effect is a reason to avoid this medication in patients with kidney disease, the elderly, or heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. Seek immediate medical attention and discontinue Sitagliptin/Metformin if these symptoms occur.
Sitabetic-M 50/500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitabetic-M 50/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitabetic-M 50/500 Tablets are contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitabetic-M 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sitabetic-M 50/500) can cause lactic acidosis, a serious, potentially life-threatening buildup of lactic acid in the blood (also known as MALA—Metformin-associated lactic acidosis). This is a rare but serious side effect, particularly in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitabetic-M 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitabetic-M 50/500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitabetic-M 50/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitabetic-M 50/500 Tablets are contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitabetic-M 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sitabetic-M 50/500) can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA, Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the drug in patients with kidney disease, older adults, or heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. Seek immediate medical attention and discontinue Sitagliptin/Metformin if these symptoms occur.
Prolonged Sitabetic-M 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary or cognitive issues. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitabetic-M 50/500 Tablet
280
MRP 325
13% off